Switching off a single enzyme in immune cells protected mice from obesity, type 2 diabetes, and fatty liver disease in a new study, offering a potential new treatment target for metabolic disorders.

GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are ...

Over 27 percent of adults worldwide with obesity qualify for GLP-1 weight loss medicines but access remains unequal.

Scientists may have found a new way to spot early signs of obesity, which could lead to novel prevention strategies. A study ...

Obesity is broadly defined as having a body mass index (BMI) of 30 or higher. However, there are different types of obesity classified by their severity. Although the term "morbid obesity" was used in ...

Obesity is one of the most common health issues in the world, which also triggers other diseases.Prolonged obesity can ...

A deep dive into the scientific shift toward multi-target obesity therapeutics and its implications for metabolic health and ...

The prevalence of type 2 diabetes and obesity worldwide is increasing, and these two conditions have a bidirectional and linear relationship. Obesity worsens the development of type 2 diabetes by ...

The intricate relationship between diet, metabolic disorders, and cancer progression has garnered significant attention in ...